Similar articles

• Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.

  Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M. Prondzinsky R, et al. Crit Care Med. 2010 Jan;38(1):152-60. doi: 10.1097/CCM.0b013e3181b78671. Crit Care Med. 2010. PMID: 19770739 Clinical Trial.
• Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction.

  Cheng JM, Valk SD, den Uil CA, van der Ent M, Lagrand WK, van de Sande M, van Domburg RT, Simoons ML. Cheng JM, et al. Am J Cardiol. 2009 Aug 1;104(3):327-32. doi: 10.1016/j.amjcard.2009.03.050. Epub 2009 Jun 6. Am J Cardiol. 2009. PMID: 19616662
• The Preference, Effect, and Prognosis of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock Patients: A Retrospective Cohort Study.

  Wang W, Yang F, Lin X, Zhong Q, Li Z, Chen X, Wang J, He K. Wang W, et al. Biomed Res Int. 2021 Jan 20;2021:6656926. doi: 10.1155/2021/6656926. eCollection 2021. Biomed Res Int. 2021. PMID: 33542922 Free PMC article.
• [Ischaemic cardiogenic shock. Where do we stand in 2012?].

  Leurent G. Leurent G. Ann Cardiol Angeiol (Paris). 2012 Dec;61(6):417-22. doi: 10.1016/j.ancard.2012.09.010. Epub 2012 Oct 2. Ann Cardiol Angeiol (Paris). 2012. PMID: 23083801 Review. French.
• Cardiogenic shock: basics and clinical considerations.

  Gowda RM, Fox JT, Khan IA. Gowda RM, et al. Int J Cardiol. 2008 Jan 24;123(3):221-8. doi: 10.1016/j.ijcard.2006.03.099. Epub 2007 Nov 26. Int J Cardiol. 2008. PMID: 18037513 Review.